Anti-ATP13A2 antibody [EPR26835-63] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal ATP13A2 antibody. Carrier free. Suitable for WB and reacts with Human, Mouse, Rat samples.
View Alternative Names
PARK9, ATP13A2, Polyamine-transporting ATPase 13A2
- WB
Supplier Data
Western blot - Anti-ATP13A2 antibody [EPR26835-63] - BSA and Azide free (AB303529)
This data was developed using ab303528, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
The molecular weight observed is consistent with what has been described in the literature (PMID : 27278822).
Low expression : heart (PMID : 15381061), ovary (Human Protein Atlas)
Samples are non-boiled as boiling may cause protein aggregation.
The identity of the top bands above 250 kDa is unknown.
All lanes:
Western blot - Anti-ATP13A2 antibody [EPR26835-63] (<a href='/en-us/products/primary-antibodies/atp13a2-antibody-epr26835-63-ab303528'>ab303528</a>) at 1/1000 dilution
Lane 1:
Human hypothalamus tissue lysate at 20 µg
Lane 2:
Human heart tissue lysate at 20 µg
Lane 3:
Mouse brain tissue lysate at 20 µg
Lane 4:
Mouse hypothalamus tissue lysate at 20 µg
Lane 5:
Mouse heart tissue lysate, at 20 µg
Lane 6:
Mouse ovary tissue lysate at 20 µg
Lane 7:
Rat brain tissue lysate at 20 µg
Lane 8:
Rat heart tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 129 kDa
Observed band size: 150 kDa
false
Exposure time: 5.5s
Related conjugates and formulations (1)
-
Anti-ATP13A2 antibody [EPR26835-63]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ATP13A2 plays a significant role in maintaining metal ion homeostasis inside cells. It is an essential component of the complex regulatory system that ensures proper lysosomal function. The protein impacts autophagy by influencing lysosomal biogenesis and integrity. Furthermore its function in metal ion transport and detoxification suggests a protective role for neurons against metal-induced oxidative stress.
Pathways
ATP13A2 is an important participant in the lysosomal degradation pathway and the autophagy-lysosome pathway. It interacts with proteins such as alpha-synuclein known for its role in neurodegenerative diseases and cellular stress responses. In the context of metal ion homeostasis ATP13A2 operates alongside other transporters and enzymes to maintain cellular ion balance and prevent toxicity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com